Pharmaceutical management of patients with an enterostomy device –Prospective study to optimize medication and avoid drug-related problems in patients with an artificial bowel outlet

Not Applicable

• Conditions: Z93.2; Z93.3; Ileostomy status; Colostomy status; Patients with enterostomy (new or existing)

• Registration Number: DRKS00027291
• Lead Sponsor: niversitätsklinikum Hamburg-Eppendorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-01
• Study Completion: 2023-06-30
• Results First Posted: 2024-05-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients with enterostoma (new or existing enterostoma)
- Able to communicate in German
- Written informed consent to participate in the study

Exclusion Criteria

non-applicable inclusion criteria

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) Relevance of pharmaceutical interventions for solving drug-related problems in patients with enterostoma

Secondary Outcome Measures

Name	Time	Method
1) Classification of drug-related problems and resulting pharmaceutical interventions in patients with enterostoma<br>2) Evaluation of pharmaceutical care by patients with enterostoma <br>3) Evaluation of continuous pharmaceutical care at the interface between inpatient and outpatient settings